Assessing Adherence to Home Telemedicine in Individuals With Chronic Obstructive Pulmonary Disease (COPD)

NACompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

July 1, 2020

Primary Completion Date

May 24, 2021

Study Completion Date

May 24, 2021

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DEVICE

Go Home tablet with linked GoSpiro and 3230 Pulse Oximeter

All participants will receive the intervention consisting of a home telemedicine tablet platform (GoHome) that will collect multiple spirometry tests each week (including both forced and slow spirometry measurements), pulse oximetry, and QoL Questionnaire responses. The platform will remind patients to take their medications remind patients to perform measurements, send patients helpful information, and execute a UNC clinic established COPD Action Plan.The backend of the platform is a remote server (Monitored Therapeutics CarePortal) that collects the data, send out alerts to the Principal Investigator and can track and trend the data for them.

Trial Locations (1)

27517

Meadowmont Marsico Lung Research Center, Chapel Hill

All Listed Sponsors
collaborator

Midmark Corporation

INDUSTRY

collaborator

Monitored Therapeutics, Inc

INDUSTRY

lead

University of North Carolina, Chapel Hill

OTHER

NCT04369885 - Assessing Adherence to Home Telemedicine in Individuals With Chronic Obstructive Pulmonary Disease (COPD) | Biotech Hunter | Biotech Hunter